ODDITY Tech Ltd Dossier
Qualitative Analysis
Business overview
Oddity Tech Ltd. (NASDAQ: ODD) is a consumer technology company that builds and scales digital-first brands in the beauty and wellness sectors. Operating under its proprietary AI-driven online platform, the company utilizes data science, machine learning, and computer vision to deliver personalized product recommendations, effectively bringing the beauty counter experience directly to consumers' smartphones. Its flagship brands include IL MAKIAGE (makeup and cosmetics) and SpoiledChild (skincare, haircare, and supplements), alongside its newly launched telehealth dermatology platform, METHODIQ. By bypassing traditional brick-and-mortar retail channels and selling directly to consumers (DTC), Oddity maintains high gross margins and leverages over 1 billion unique user data points to optimize product matching and customer retention.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Implementing structural adjustments, new targeting strategies, and shifting 40% of acquisition revenue from the 'Try Before You Buy' model to standard buying models to address elevated customer acquisition costs (CPA) caused by an algorithm dislocation with its largest advertising partner.
Expected impact: Reduction in customer acquisition costs (May 2026 already showed a 28% sequential decline from April) and restoration of first-order growth.
Expanding the newly launched medical telehealth platform, Methodiq, which delivers customized, high-efficacy dermatology treatments for acne, hyperpigmentation, and eczema using AI-powered skin analysis and computer vision.
Expected impact: Expected to generate $25 million in revenue in its first year, matching the year-one trajectory of SpoiledChild.
Ongoing development and expansion of the ODDITY Labs molecule discovery platform in Boston, utilizing AI-based drug discovery technology to develop proprietary, science-backed, and clinically tested ingredients for beauty and wellness products.
Expected impact: Powers product innovation across current and future brands, creating a proprietary technology moat and highly efficacious products.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
To acquire an industry-leading biotechnology startup and forerunner in AI-based molecule discovery, establishing ODDITY Labs in Boston to bring pharma-grade technology to beauty and wellness.
Financial impact: Formed the core of ODDITY's proprietary product development engine, powering ingredients for brands like SpoiledChild and Methodiq.
To acquire hyperspectral imaging software technology, allowing smartphone cameras to analyze skin characteristics at 31 wavelengths of light to power online matching algorithms.
Financial impact: Enabled advanced computer vision capabilities utilized in the PowerMatch and SpoiledBrain recommendation engines.